SCHEMBL6567546

SCHEMBL6567546

O=C(Nc1cc(Br)c(O)c(Br)c1)NC1CC1c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.64
EPHX2 P34913 6/20 0.53
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
IDH1 O75874 1/20 0.49
TLR2 O60603 3/20 0.49
TLR1 Q15399 3/20 0.49
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
MET P08581 3/20 0.44
HRH3 Q9Y5N1 1/20 0.44
FPR1 P21462 2/20 0.44
FPR2 P25090 2/20 0.44
CHEK1 O14757 1/20 0.43
AURKA O14965 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567565 0.84 CNR1 (0.71) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL6567236 0.83 CNR1 (0.62) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL22834153 0.78 CNR1 (1.00) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL22834156 0.78 CNR1 (1.00) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL22834265 0.78 CNR1 (1.00) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL9667225 0.78 SMN1; SMN2 (0.67) CNR1EPHX2SMN1; SMN2NPSR1TLR2
SCHEMBL4350351 0.76 SMN1; SMN2 (0.63) EPHX2SMN1; SMN2NPSR1CA1CA2
SCHEMBL6568595 0.75 CNR1 (0.59) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL6566899 0.75 CNR1 (0.55) CNR1EPHX2SMN1; SMN2NPSR1IDH1
SCHEMBL6568477 0.74 CNR1 (0.68) CNR1EPHX2SMN1; SMN2NPSR1IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed